Stemcells (STEM) Misses Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts STEM Hot Sheet
Join SI Premium – FREE
Stemcells (NASDAQ: STEM) reported Q2 EPS of ($0.22), $0.08 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $242 thousand versus the consensus estimate of $260 thousand.
For earnings history and earnings-related data on Stemcells (STEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Tenon Medical (TNON) Misses Q2 EPS by 395c
- Workhorse Group (WKHS) Misses Q2 EPS by 77c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
